Financhill
Back

Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.
Sell
36

AUPH
Aurinia Pharmaceuticals

Last Price:
5.09
Seasonality Move:
-6.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Aurinia Pharmaceuticals Price Quote

$5.09
+0.08 (+1.6%)
(Updated: April 30, 2024 at 11:25 AM ET)

Aurinia Pharmaceuticals Key Stats

Sell
36
Aurinia Pharmaceuticals (AUPH) is a Sell

Day range:
$4.92 - $5.07
52-week range:
$4.71 - $12.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.08
P/B ratio:
1.92%

Volume:
939.2K
Avg. volume:
1.3M
1-year change:
-55.47%
Market cap:
$724.5M
Revenue:
$175.5M
EPS:
$-0.53

How Much Does Aurinia Pharmaceuticals Make?

Is Aurinia Pharmaceuticals Growing As A Company?

Aurinia Pharmaceuticals Stock Price Performance

What Is Aurinia Pharmaceuticals 52-Week High & Low?

Aurinia Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aurinia Pharmaceuticals?

Is Aurinia Pharmaceuticals Cash Flow Positive?

  • What Is AUPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.5M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.1M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.7M

Aurinia Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AUPH return on invested capital is -19.92%
  • What Is Aurinia Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -15.15%
  • What Is AUPH Return On Equity?
    ROE is a measure of profitability and is -19.92%

Aurinia Pharmaceuticals Earnings Date & Stock Price

Aurinia Pharmaceuticals Competitors

Aurinia Pharmaceuticals Dividend Yield

Data Unavailable

Aurinia Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -16.33%
Revenue: 58.59% -0.14%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.57
Upside from Last Price: 111.01%

Major Shareholders

  • How many AUPH shares are owned by institutional investors?
    80.5M AUPH shares are owned by institutional investors
  • How many AUPH shares are owned by insiders?
    4.6M AUPH shares are owned by insiders